Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Hepatology ; 47(6): 1983-93, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18459124

ABSTRACT

UNLABELLED: Hepatic stellate cells (HSCs) contribute to portal hypertension through multiple mechanisms that include collagen deposition, vasoconstriction, and regulation of sinusoidal structure. Under normal physiologic conditions, endothelial nitric oxide (NO) synthase-derived NO exerts paracrine effects on HSCs; however, in cirrhosis, NO generation is impaired in association with concomitant HSC activation and changes in sinusoidal structure, events that contribute significantly to the development of portal hypertension. These concepts, in combination with recent evidence that induction of HSC-selective apoptosis may represent a useful target for treatment of chronic liver disease, led us to examine if NO may further limit HSC function through apoptosis. Indeed, both NO donors and endothelial NO synthase overexpression promoted HSC apoptotic pathways. HSC death conferred by NO occurred through mitochondrial membrane depolarization and through a caspase-independent pathway. Furthermore, NO-induced apoptosis of HSC did not occur through the canonical pathways of soluble guanylate cyclase or protein nitration, but rather through the generation of superoxide and hydroxyl radical intermediates. Lastly, HSC isolated from rats after bile duct ligation were more susceptible to NO-induced apoptosis. These data indicate that NO promotes HSC apoptosis through a signaling mechanism that involves mitochondria, is mediated by reactive oxygen species, and occurs independent of caspase activation. CONCLUSION: We postulate that NO-dependent apoptosis of HSCs may maintain sinusoidal homeostasis, and may represent an additional beneficial effect of NO donors for therapy of portal hypertension.


Subject(s)
Apoptosis/physiology , Caspases/metabolism , Hepatocytes/metabolism , Hepatocytes/pathology , Nitric Oxide/metabolism , Reactive Oxygen Species/metabolism , Animals , Apoptosis/drug effects , Cells, Cultured , Guanylate Cyclase/metabolism , Hepatocytes/drug effects , Homeostasis/physiology , Humans , Hydroxyl Radical/metabolism , Male , Nitric Oxide Donors/pharmacology , Nitroprusside/pharmacology , Rats , Rats, Sprague-Dawley , Signal Transduction/physiology , Superoxides/metabolism
2.
J Cell Sci ; 120(Pt 3): 492-501, 2007 Feb 01.
Article in English | MEDLINE | ID: mdl-17251380

ABSTRACT

Endothelial cell-based angiogenesis requires activation of survival signals that generate resistance to external apoptotic stimuli, such as tumor necrosis factor-alpha (TNF-alpha), during pathobiologic settings. Mechanisms by which this is achieved are not fully defined. Here, we use a model in which the multifunctional cytokine nitric oxide counterbalances TNF-alpha-induced apoptosis, to define a role for membrane trafficking in the process of endothelial cell survival signaling. By perturbing dynamin GTPase function, we identify a key role of dynamin for ensuing downstream endothelial cell survival signals and vascular tube formation. Furthermore, nitric oxide is directly demonstrated to promote dynamin function through specific cysteine residue nitrosylation, which promotes endocytosis and endothelial cell survival signaling. Thus, these studies identify a novel role for dynamin as a survival factor in endothelial cells, through a mechanism by which dynamin S-nitrosylation regulates the counterbalances of TNF-alpha-induced apoptosis and nitric oxide-dependent survival signals, with implications highly relevant to angiogenesis.


Subject(s)
Dynamin II/metabolism , Endothelial Cells/metabolism , Nitric Oxide/metabolism , Nitrogen/chemistry , Signal Transduction , Alanine/metabolism , Amino Acid Substitution , Animals , Aorta/cytology , Cattle , Cell Line , Dynamin II/chemistry , Dynamin II/genetics , Endothelial Cells/cytology , Endothelium, Vascular/cytology , Escherichia coli/genetics , Glutathione Transferase/metabolism , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/isolation & purification , Recombinant Fusion Proteins/metabolism , Transfection
3.
FASEB J ; 19(12): 1692-4, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16049137

ABSTRACT

Vascular endothelial growth factor receptor-2 (VEGFR-2, also known as KDR) is a receptor tyrosine kinase (RTK) regulating mitogenic, chemotactic, permeability, and survival signals in vascular endothelial cells (EC) in response to its ligand, vascular permeability factor/VEGF (VPF/VEGF), arguably the most important angiogenic cytokine. However, the compartmentalization of KDR in EC and the mechanisms regulating this process have not been well defined. Here, we demonstrate that KDR is present on the plasma membrane, on endosomes, and in the perinuclear region of EC and colocalizes with early endosomal antigen (EEA1), caveolin-1, and dynamin-2, a signal transducing GTPase involved in receptor endocytosis. Furthermore, we also observed that dynamin-2 coimmunoprecipitates with KDR and is required for EC signaling/survival. Interestingly, EC overexpressing a mutant form of dynamin deficient in GTP binding (K44A) caused a selective inhibition in KDR protein level and endosomal vesicle formation and induced cell cycle arrest by inducing p21. Taken together, our findings suggest that dynamin-2 regulates KDR expression and function and hence plays an important role in VPF/VEGF mediated angiogenesis.


Subject(s)
Dynamin II/biosynthesis , Dynamin II/physiology , Endothelium, Vascular/metabolism , Signal Transduction , Vascular Endothelial Growth Factor A/chemistry , Vascular Endothelial Growth Factor Receptor-2/metabolism , Blotting, Western , Caveolin 1/metabolism , Cell Cycle , Cell Membrane/metabolism , Cell Proliferation , Cell Separation , Cells, Cultured , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Cytokines/metabolism , Endocytosis , Endosomes/metabolism , Endothelium, Vascular/cytology , Flow Cytometry , GTP Phosphohydrolases/metabolism , Guanosine Triphosphate/chemistry , Humans , Immunoprecipitation , Membrane Proteins/metabolism , Microscopy, Fluorescence , Models, Statistical , Mutation , Neovascularization, Pathologic , Protein Binding , Reverse Transcriptase Polymerase Chain Reaction , Umbilical Veins/cytology , Vesicular Transport Proteins
4.
Am J Pathol ; 166(6): 1861-70, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15920170

ABSTRACT

Migration of pericytes such as hepatic stellate cells is fundamentally important for diverse biological and pathological processes including tumor invasion and fibrosis. In prototypical migratory cells such as fibroblasts, the small GTPases Rac1 and RhoA govern the assembly of lamellipodia and stress fibers, respectively, cytoskeletal structures that are integral to the cell migration process. The gaseous signaling molecule nitric oxide (NO) influences growth factor chemotactic responses, although this occurs primarily in cell-type-specific ways and through cell biological effects that are poorly characterized. In this study, we use complementary molecular and cell biological approaches to delineate important roles for Rac1, RhoA, and NO in migration of the human hepatic stellate cell line LX2 and primary rat hepatic stellate cells. Both platelet-derived growth factor (PDGF) and Rac1 overexpression drove migration through formation of actin-positive filopodia spikes in LX2 as compared to the formation of lamellipodia in fibroblasts. NO inhibited PDGF- and Rac1-driven migration in LX2 by abrogating filopodia formation and inhibited migration of fibroblasts by attenuating lamellipodial protrusions. Additionally, RhoA conferred resistance to NO inhibition of migration and restored chemotactic responses to PDGF in the absence of functional Rac1 in LX2. In conclusion, these studies identify novel crosstalk between small GTPases, cytoskeletal structures, and NO in pericyte-specific pathways, providing counterbalances in the chemotactic responses to growth factors.


Subject(s)
Actins/metabolism , Cell Movement/physiology , Fibroblasts/metabolism , Nitric Oxide/metabolism , Pericytes/metabolism , Signal Transduction/physiology , rho GTP-Binding Proteins/metabolism , Animals , Blotting, Western , Cell Membrane/metabolism , Cells, Cultured , Fibroblasts/cytology , Humans , Pericytes/cytology , Platelet-Derived Growth Factor/metabolism , Pseudopodia/metabolism , Rats , rac1 GTP-Binding Protein/metabolism
5.
Cancer Cell ; 5(2): 177-89, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14998493

ABSTRACT

CBP can function as a tumor suppressor, but the mechanisms that govern oncogenesis in its absence are unknown. Here we show that CBP inactivation in mouse thymocytes leads to lymphoma. Although CBP has been implicated in the transactivation functions of p53, development of these tumors does not seem to involve loss of p53 activity. CBP-null tumors show reduced levels of p27Kip1 and increased levels of cyclin E and Skp2, two oncoproteins that can promote p27Kip1 proteolysis. Reduction of p27Kip1 by introduction of a p27Kip1-null allele into CBP knockout mice accelerates lymphomagenesis and seems to obviate the requirement for Skp2 and cyclin E upregulation. These data suggest that CBP loss mediates lymphomagenesis in cooperation with a mechanism that reduces p27Kip1 abundance.


Subject(s)
Cell Cycle Proteins/metabolism , Lymphoma, T-Cell/metabolism , Nuclear Proteins/metabolism , Repressor Proteins , T-Lymphocytes/metabolism , Trans-Activators/metabolism , Tumor Suppressor Proteins/metabolism , Animals , CREB-Binding Protein , Cloning, Molecular , Cyclin E/metabolism , Cyclin-Dependent Kinase Inhibitor p27 , DNA Damage/physiology , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Genes, myc/physiology , Genetic Predisposition to Disease , Lymphoma, T-Cell/genetics , Membrane Proteins/metabolism , Mice , Mice, Knockout , Microscopy, Fluorescence , Nuclear Proteins/genetics , Polycomb Repressive Complex 1 , Proto-Oncogene Proteins/metabolism , Receptors, Notch , S-Phase Kinase-Associated Proteins/metabolism , T-Lymphocytes/pathology , Trans-Activators/genetics , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism , Up-Regulation/physiology
6.
Biol Reprod ; 70(5): 1400-10, 2004 May.
Article in English | MEDLINE | ID: mdl-14724135

ABSTRACT

Acrosome biogenesis involves the transport and fusion of Golgi-derived proacrosomal vesicles along the acroplaxome, an F-actin/keratin 5-containing cytoskeletal plate anchored to the spermatid nucleus. A significant issue is whether the acroplaxome develops in acrosomeless mutant mice. Male mice with a Hrb null mutation are infertile and both spermatids and sperm are round-headed and lack an acrosome. Hrb, a protein that contains several NPF motifs (Asn-Pro-Phe) and interacts with proteins with Eps15 homology domains, is regarded as critical for the docking and/or fusion of Golgi-derived proacrosomal vesicles. Here we report that the lack of an acrosome in Hrb mutant spermatids does not prevent the development of the acroplaxome. Yet the acroplaxome in the mutant contains F-actin but is deficient in keratin 5. We also show that the actin-based motor protein myosin Va and its receptor, Rab27a/b, known to be involved in vesicle transport, are present in the Golgi and Golgi-derived proacrosomal vesicles in wild-type and Hrb mutant mouse spermatids. In the Hrb mutant, myosin-Va-bound proacrosome vesicles tether to the acroplaxome, where they flatten and form a flat sac, designated pseudoacrosome. As spermiogenesis advances, round-shaped spermatid nuclei of the mutant display several nuclear protrusions, designated nucleopodes. Nucleopodes are consistently found at the acroplaxome- pseudoacrosome site. Our findings support the interpretation that the acroplaxome provides a focal point for myosin-Va/ Rab27a/b-driven proacrosomal vesicles to accumulate, coalesce, and form an acrosome in wild-type spermatids and a pseudoacrosome in Hrb mutant spermatids. We suggest that nucleopodes develop at a site where a keratin 5-deficient acroplaxome may not withstand tension forces operating during spermatid nuclear shaping.


Subject(s)
Acrosome/physiology , Carrier Proteins/genetics , Golgi Apparatus/metabolism , Mutation , Myosin Heavy Chains/metabolism , Myosin Type V/metabolism , Spermatids/physiology , rab GTP-Binding Proteins/metabolism , Actins/metabolism , Adaptor Proteins, Vesicular Transport , Animals , Fluorescent Antibody Technique, Indirect , Immunohistochemistry , Keratin-15 , Keratin-5 , Keratins/deficiency , Male , Mice , Microscopy, Electron , Microscopy, Immunoelectron , Spermatids/ultrastructure , rab27 GTP-Binding Proteins
7.
J Cell Biol ; 160(3): 341-53, 2003 Feb 03.
Article in English | MEDLINE | ID: mdl-12551952

ABSTRACT

The WD-repeat proteins Rae1 and Bub3 show extensive sequence homology, indicative of functional similarity. However, previous studies have suggested that Rae1 is involved in the mRNA export pathway and Bub3 in the mitotic checkpoint. To determine the in vivo roles of Rae1 and Bub3 in mammals, we generated knockout mice that have these genes deleted individually or in combination. Here we show that haplo-insufficiency of either Rae1 or Bub3 results in a similar phenotype involving mitotic checkpoint defects and chromosome missegregation. We also show that overexpression of Rae1 can correct for Rae1 haplo-insufficiency and, surprisingly, Bub3 haplo-insufficiency. Rae1-null and Bub3-null mice are embryonic lethal, although cells from these mice did not have a detectable defect in nuclear export of mRNA. Unlike null mice, compound haplo-insufficient Rae1/Bub3 mice are viable. However, cells from these mice exhibit much greater rates of premature sister chromatid separation and chromosome missegregation than single haplo-insufficient cells. Finally, we show that mice with mitotic checkpoint defects are more susceptible to dimethylbenzanthrene-induced tumorigenesis than wild-type mice. Thus, our data demonstrate a novel function for Rae1 and characterize Rae1 and Bub3 as related proteins with essential, overlapping, and cooperating roles in the mitotic checkpoint.


Subject(s)
Cell Cycle Proteins/metabolism , Chromosome Aberrations/embryology , Chromosome Segregation/genetics , Genes, cdc/physiology , Mitosis/genetics , Nuclear Matrix-Associated Proteins/deficiency , Nucleocytoplasmic Transport Proteins/deficiency , Active Transport, Cell Nucleus/genetics , Aneuploidy , Animals , Cell Cycle Proteins/genetics , Cell Transformation, Neoplastic/genetics , Cells, Cultured , Chromosomal Proteins, Non-Histone , Female , Fetus , Gene Expression Regulation, Developmental/genetics , Genes, Lethal/physiology , Genetic Predisposition to Disease/genetics , Male , Mice , Mice, Knockout , Nuclear Matrix-Associated Proteins/genetics , Nucleocytoplasmic Transport Proteins/genetics , Phenotype , Poly-ADP-Ribose Binding Proteins , RNA, Messenger/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...